Palisade Bio

Acquired

Advancing Next-Generation Precision Therapies

Public · Carlsbad, United States · Founded 2011

Founded
2011
Business Model
B2B
Type
Public

About

Palisade Bio is a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs for inflammatory and fibrotic diseases. Its lead program, PALI-2108, is designed for targeted bioactivation in the ileum and colon to improve pharmacology, tolerability, and convenience for patients with inflammatory bowel disease, and the company is advancing toward Phase 2 studies in ulcerative colitis and Crohn's disease. Palisade Bio trades on Nasdaq under the ticker PALI and was originally founded in 2011 as Leading BioSciences, Inc.

Summary

Palisade Bio is a Biotech company based in Carlsbad, United States, founded in 2011.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketOct 2025

Sign up to see all 2 rounds

Merger through Secondary Market — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Palisade Bio on Indexed.vc
<a href="https://indexed.vc/companies/palisade-bio"><img src="https://indexed.vc/api/badge/company/palisade-bio" alt="Palisade Bio on Indexed.vc" width="260" height="76" /></a>